Federal Funding Opportunities December 12th-16th, 2022

National Institutes of Health:

• Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
  (PAR-23-042)
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Office of Disease Prevention
  Application Receipt Date(s): March 09, 2023
• NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
  (PAR-23-058)
  National Cancer Institute
  Application Receipt Date(s): February 22, June 20, October 17 annually
• Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
  (PAR-23-067)
  Office of the Director, NIH
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): January 07, 2026
• Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
  (RFA-AT-23-008)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Application Receipt Date(s): January 10, 2023
• NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 – Independent Clinical Trial Not Allowed)
  (RFA-DK-22-012)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 28, 2023
• Supporting the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
  (RFA-FD-23-025)
  Food and Drug Administration
  Application Receipt Date(s): February 28, 2023